Abbott Duspatalin Retard 200 mg 30 Capsules is a medicine registered with the Saudi Food and Drug Authority. It contains the active ingredient Mebeverine Hydrochloride 200 mg, and its pharmaceutical form is capsule. This medicine is available on prescription only.
Medicine Details
- Registered Trade Name: DUSPATALIN 200MG PROLONGED RELEASE CAPS
- Active Ingredient and Strength: Mebeverine Hydrochloride 200 mg
- Pharmaceutical Form: Capsule
- Route of Administration: Oral
- Marketing Authorisation Holder: ABBOTT BIOLOGICALS (Netherlands)
- ATC Classification Code: A03AA04
Prescription Requirement
This medicine is dispensed only against a valid prescription from a licensed doctor. When ordering from the store, upload a prescription image for the pharmacist to review before preparing the order. The dose and duration of use are determined solely by the treating doctor.
Storage
Store at room temperature not exceeding 30 degrees Celsius. Keep out of reach of children.
Registration Information
Registered with the Saudi Food and Drug Authority under number 0604233492.
The information above provides identification details from the Saudi Food and Drug Authority register and does not replace the treating doctor's instructions, the patient leaflet, or consultation with a pharmacist.